BACKGROUND: Although continuous positive airway pressure therapy (CPAP) is the treatment of choice for obstructive sleep apnoea syndrome (OSAS), there is a portion of patients in which CPAP is not usable. Bilevel treatment serves as an alternative for these patients. For uncomplicated OSAS, auto-adjusting CPAP based on the forced oscillation technique (APAPFOT) has proved to be equally as effective as constant CPAP, and is preferred by the patients. The aim of this study was to investigate the question whether, in the event of primary CPAP intolerance, high pressures (>or =12 cm H2O) or SAS with > or =10% central respiratory disorders, APAPFOT is as effective as bilevel therapy in reducing respiratory disturbances. MATERIAL/ METHODS: 27 patients (23 m, 4 f, age 57.2+/-13.1 years, BMI 33.5+/-7.8 kg/m2) were treated with bilevel and APAPFOT for 6 weeks each in a prospective randomized cross-over study. The efficacy of the treatment modes was examined polysomnographically. RESULTS: Both modalities significantly improved the respiratory disturbances (AHI: baseline 49+/-27.3/h, bilevel 9.8+/-12.5, p<0.01, APAPFOT 13.8+/-13.2, p<0.01) and sleep quality (arousals: baseline 43+/-28.3/h, bilevel 17.7+/-8.8, p<0.01, APAPFOT 20.5+/-10.7, p<0.01), with no significant differences between the modalities. Under APAPFOT, mean treatment pressure was substantially reduced (bilevel 8.3+/-2.5, APAPFOT 5.1+/-1.7, p<0.01). The majority of patients gave preference to APAPFOT for long-term treatment (21 vs. 6 patients, p<0.05). CONCLUSIONS: In patients with difficult-to-treat OSAS, APAPFOT has proved to be just as effective as bilevel therapy, but has the advantage of meeting with greater acceptance.
RCT Entities:
BACKGROUND: Although continuous positive airway pressure therapy (CPAP) is the treatment of choice for obstructive sleep apnoea syndrome (OSAS), there is a portion of patients in which CPAP is not usable. Bilevel treatment serves as an alternative for these patients. For uncomplicated OSAS, auto-adjusting CPAP based on the forced oscillation technique (APAPFOT) has proved to be equally as effective as constant CPAP, and is preferred by the patients. The aim of this study was to investigate the question whether, in the event of primary CPAP intolerance, high pressures (>or =12 cm H2O) or SAS with > or =10% central respiratory disorders, APAPFOT is as effective as bilevel therapy in reducing respiratory disturbances. MATERIAL/ METHODS: 27 patients (23 m, 4 f, age 57.2+/-13.1 years, BMI 33.5+/-7.8 kg/m2) were treated with bilevel and APAPFOT for 6 weeks each in a prospective randomized cross-over study. The efficacy of the treatment modes was examined polysomnographically. RESULTS: Both modalities significantly improved the respiratory disturbances (AHI: baseline 49+/-27.3/h, bilevel 9.8+/-12.5, p<0.01, APAPFOT 13.8+/-13.2, p<0.01) and sleep quality (arousals: baseline 43+/-28.3/h, bilevel 17.7+/-8.8, p<0.01, APAPFOT 20.5+/-10.7, p<0.01), with no significant differences between the modalities. Under APAPFOT, mean treatment pressure was substantially reduced (bilevel 8.3+/-2.5, APAPFOT 5.1+/-1.7, p<0.01). The majority of patients gave preference to APAPFOT for long-term treatment (21 vs. 6 patients, p<0.05). CONCLUSIONS: In patients with difficult-to-treat OSAS, APAPFOT has proved to be just as effective as bilevel therapy, but has the advantage of meeting with greater acceptance.
Authors: John Fleetham; Najib Ayas; Douglas Bradley; Michael Fitzpatrick; Thomas K Oliver; Debra Morrison; Frank Ryan; Frederick Series; Robert Skomro; Willis Tsai Journal: Can Respir J Date: 2011 Jan-Feb Impact factor: 2.409
Authors: Clete A Kushida; Alejandro Chediak; Richard B Berry; Lee K Brown; David Gozal; Conrad Iber; Sairam Parthasarathy; Stuart F Quan; James A Rowley Journal: J Clin Sleep Med Date: 2008-04-15 Impact factor: 4.062